ciprofloxacin has been researched along with agar in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.70) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 5 (18.52) | 29.6817 |
| 2010's | 5 (18.52) | 24.3611 |
| 2020's | 13 (48.15) | 2.80 |
| Authors | Studies |
|---|---|
| Dalhoff, A; Konrad-Dalhoff, I | 1 |
| Alós, JI; Cogollos, R; Gómez-Garcés, JL | 1 |
| Barbarini, D; Bono, L; Carretto, E; Marone, P; Telecco, S | 1 |
| Barrett, MS; Deguchi, T; Jones, RN | 1 |
| Appelbaum, PC; Ednie, LM; Jacobs, MR | 1 |
| Bajaksouzian, S; Jacobs, MR; Joloba, ML | 1 |
| Borobio, MV; de La Rosa, M; Domínguez, MC | 1 |
| Gaudreau, C; Girouard, Y; Ringuette, L; Tsimiklis, C | 1 |
| Gopinath, K; Sankar, MM; Singh, S; Singla, R | 1 |
| Amison, R; Banner, KH; Coulthard, A; Grevot, A; Growcott, EJ; Hardaker, EL; Jones, P; Malt, L; Osborne, C; Poll, C; Saxena, V | 1 |
| Choi, JW; Kim, SG; Park, YH; Rha, KS; Yoon, YH | 1 |
| Audisio, MC; Gorustovich, A; Rivadeneira, J | 1 |
| Boss, J; Chanthongthip, A; Dance, DAB; Newton, PN; Robinson, MT; Wuthiekanun, V | 1 |
| Awad, R; Couet, W; Marchand, S; Tewes, F; Torres, BGS | 1 |
| Shimekaw, M; Tessema, B; Tigabu, A | 1 |
| Habeeb Rasool, K; Hammood Hussein, N; Mahamed Taha, B | 1 |
| Coombs, GW; Daley, DA; Mowlaboccus, S; Shoby, P; Yee, NWT | 1 |
| Barazzetti, FH; Bazzo, ML; de Albuquerque, VCB; de Melo Machado, H; Golfetto, L; Martins, JM; Santos, TMD; Scheffer, MC; Schörner, MA | 1 |
| Cristino, S; Girolamini, L; Grottola, A; Mazzotta, M; Orsini, M; Pascale, MR; Salaris, S; Zini, N | 1 |
| Debelo, M; Mohammed, N; Tiruneh, A; Tolosa, T | 1 |
| Abbas Tikki, K; Hayder Hasan, T; Sabah Bustani, G; Sadeq Al-Ethari, A | 1 |
| Coombs, GW; Daley, DA; Mowlaboccus, S; Shoby, P | 2 |
| Belayhun, C; Belete, MA; Demsiss, W; Seid, A; Sharew, B; Shibabaw, A; Tilahun, M | 1 |
| Khan, M; Ma, K; Wan, I; Willcox, MD | 1 |
| Miriti, DM; Muthini, JM; Nyamache, AK | 1 |
| Dingle, TC; Ferrato, C; Gratrix, J; Ma, A; Martin, I; Smyczek, P | 1 |
27 other study(ies) available for ciprofloxacin and agar
| Article | Year |
|---|---|
Antibacterial activity of ciprofloxacin against immobilized Pseudomonas aeruginosa.
Topics: Agar; Alginates; Ciprofloxacin; Culture Media; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1987 |
[The E test and quinolone-resistant Campylobacter jejuni].
Topics: Agar; Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Evaluation Studies as Topic; Indicator Dilution Techniques; Microbial Sensitivity Tests; Sensitivity and Specificity | 1995 |
Rapid drug susceptibility of Mycobacterium avium complex using a fluorescence quenching method.
Topics: Acquired Immunodeficiency Syndrome; Agar; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Fluoroimmunoassay; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Nucleic Acid Hybridization; Rifabutin | 1997 |
Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etest results.
Topics: Agar; Anti-Infective Agents; Bacteriological Techniques; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Drug Stability; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Neisseria gonorrhoeae; Sensitivity and Specificity; Species Specificity | 1997 |
Activity of gemifloxacin, a new broad-spectrum quinolone, against 200 pneumococci by four different susceptibility testing methods.
Topics: Agar; Anti-Infective Agents; Ciprofloxacin; Culture Media; Diffusion; Drug Resistance, Microbial; Fluoroquinolones; Gemifloxacin; Indicator Dilution Techniques; Microbial Sensitivity Tests; Naphthyridines; Streptococcus pneumoniae | 2000 |
Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.
Topics: Agar; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin | 2000 |
Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar.
Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Escherichia coli; Gentamicins; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Spectrophotometry; Staphylococcus aureus | 2001 |
Comparison of disk diffusion and agar dilution methods for erythromycin and ciprofloxacin susceptibility testing of Campylobacter jejuni subsp. jejuni.
Topics: Agar; Anti-Bacterial Agents; Campylobacter jejuni; Ciprofloxacin; Colony Count, Microbial; Diffusion; Erythromycin; Microbial Sensitivity Tests | 2007 |
In-vitro antimycobacterial drug susceptibility testing of non-tubercular mycobacteria by tetrazolium microplate assay.
Topics: Agar; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Culture Media; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Reproducibility of Results; Species Specificity; Tetrazolium Salts; Time Factors | 2008 |
Characterisation of a refined rat model of respiratory infection with Pseudomonas aeruginosa and the effect of ciprofloxacin.
Topics: Acute Disease; Agar; Animals; Anti-Infective Agents; Bacterial Load; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Disease Models, Animal; Hexoses; Leukocyte Count; Male; Microspheres; Neutrophils; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Time Factors; Treatment Outcome | 2011 |
Effect of furanone on experimentally induced Pseudomonas aeruginosa biofilm formation: in vitro study.
Topics: Agar; Anti-Infective Agents; Biofilms; Ciprofloxacin; Colony Count, Microbial; Culture Media; Furans; Humans; In Vitro Techniques; Microscopy, Electron, Scanning; Middle Ear Ventilation; Pseudomonas aeruginosa | 2012 |
Films based on soy protein-agar blends for wound dressing: Effect of different biopolymer proportions on the drug release rate and the physical and antibacterial properties of the films.
Topics: Agar; Anti-Bacterial Agents; Bandages; Ciprofloxacin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Soybean Proteins; Staphylococcal Infections; Staphylococcus aureus; Wound Healing | 2018 |
Antimicrobial Susceptibility Testing of
Topics: Agar; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Culture Media; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Humans; Laos; Leptospira; Leptospirosis | 2019 |
In vitro evaluation of Pseudomonas aeruginosa chronic lung infection models: Are agar and calcium-alginate beads interchangeable?
Topics: Agar; Alginates; Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Models, Animal; Lung; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tobramycin | 2019 |
Bacterial Profile, Antimicrobial Susceptibility Pattern, and Associated Risk Factors Among Patients With Wound Infections at Debre Markos Referral Hospital, Northwest, Ethiopia.
Topics: Agar; Anti-Bacterial Agents; Bacteria; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethiopia; Gentamicins; Hospitals; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Referral and Consultation; Risk Factors; Staphylococcus aureus; Wound Infection | 2022 |
Molecular Detection of
Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cefepime; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genotype; Humans; Inhibitory Concentration 50; Iraq; Microbial Sensitivity Tests; Nalidixic Acid; Polymerase Chain Reaction; Salmonella typhi; Tobramycin; Typhoid Fever | 2020 |
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2020.
Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Australia; Bacteremia; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Tetracyclines | 2022 |
Spectinomycin, gentamicin, and routine disc diffusion testing: An alternative for the treatment and monitoring of multidrug-resistant Neisseria gonorrhoeae?
Topics: Agar; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Gentamicins; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Spectinomycin | 2022 |
Topics: Agar; Bacterial Typing Techniques; Base Composition; Catalase; Charcoal; Ciprofloxacin; Cycloheximide; Cysteine; DNA, Bacterial; Fatty Acids; Gelatinases; Glycine; Hippurates; Legionella; Nucleotides; Phylogeny; Polymyxin B; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Water | 2022 |
Isolation, identification and antibiotic resistance profile of thermophilic Campylobacter species from Bovine, Knives and personnel at Jimma Town Abattoir, Ethiopia.
Topics: Abattoirs; Agar; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Cattle; Cefixime; Ceftriaxone; Cephalothin; Chloramphenicol; Ciprofloxacin; Clindamycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Microbial; Ethiopia; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Tetracycline | 2022 |
Genotypic Detection of
Topics: Agar; Amikacin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Ciprofloxacin; Citrobacter koseri; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections | 2022 |
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP).
Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Australia; Bacteremia; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 2022 |
Asymptomatic nasopharyngeal bacterial carriage, multi-drug resistance pattern and associated factors among primary school children at Debre Berhan town, North Shewa, Ethiopia.
Topics: Adult; Agar; Child; Ciprofloxacin; Coagulase; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethiopia; Humans; Microbial Sensitivity Tests; Middle Aged; Nasopharynx; Schools; Staphylococcus aureus; Tobacco Smoke Pollution | 2023 |
Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates.
Topics: Agar; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Gentamicins; Humans; Imipenem; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2023 |
Study of bacterial respiratory infections and antimicrobial susceptibility profile among antibiotics naive outpatients visiting Meru teaching and referral hospital, Meru County, Kenya in 2018.
Topics: Agar; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Humans; Kenya; Outpatients; Piperacillin; Respiratory Tract Infections; Staphylococcal Infections | 2023 |
Use of genome sequencing to resolve differences in gradient diffusion and agar dilution antimicrobial susceptibility testing performance of
Topics: Agar; Alberta; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Retrospective Studies; Tetracycline | 2023 |
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP) Bloodstream Infection Annual Report 2022.
Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Australia; Bacteremia; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 2023 |